Prescription Required.
Is the active ingredient in the medication.
Chronic myeloid leukemia (CML) in chronic phase, accelerated phase, or blast crisis.
Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ ALL) in adults.
Some forms of myeloproliferative neoplasms (MPN) like chronic myelomonocytic leukemia (CMML) and myelofibrosis.
Spnib 50 Tablet (Dasatinib) is a tyrosine kinase inhibitor (TKI). It works by blocking the activity of certain enzymes, specifically BCR-ABL and SRC kinases, that are abnormally activated in cancer cells. By inhibiting these enzymes, dasatinib helps to stop the growth and spread of cancer cells.
Store dasatinib at room temperature, away from moisture and heat. Keep it in its original container and keep it out of the reach of children and pets.
The dosage of dasatinib is determined by your doctor and will vary depending on your individual needs.
It is usually taken by mouth with or without food.
Take dasatinib exactly as prescribed. Do not miss any doses or take more than the recommended amount.
It is important to follow your doctor's instructions carefully and to take the medication as directed.
It is important to take dasatinib consistently to ensure its effectiveness.
Fluid retention (edema), especially in the legs and ankles.
Diarrhea.
Nausea and vomiting.
Fatigue.
Headache.
Muscle pain.
Rash.
Serious side effects, including liver problems, heart problems, and bleeding.
Alcohol may interact with dasatinib. Consult your doctor about alcohol consumption while taking this medication.
Dasatinib can cause dizziness or drowsiness. Avoid driving or operating machinery until you know how dasatinib affects you.
Dasatinib can harm an unborn baby. It is not recommended for use during pregnancy. Consult your doctor immediately if you become pregnant.
Dasatinib is not typically used in children. Consult your doctor for guidance.
Dasatinib can affect kidney function. It is important to monitor kidney function while taking dasatinib.
Dasatinib can affect liver function. It is important to monitor liver function while taking dasatinib.
https://www.fda.gov/drugs/resources-information-approved-drugs/dasatinib
https://www.drugs.com/dasatinib.html
https://www.mayoclinic.org/diseases-conditions/chronic-myeloid-leukemia/diagnosis-treatment/drc-20354496
